Epinephrine Dosing in Pediatric Cardiac Arrest
Administer epinephrine 0.01 mg/kg (10 mcg/kg) IV/IO every 3-5 minutes with a maximum single dose of 1 mg, using the 1:10,000 concentration (0.1 mg/mL), regardless of acute kidney injury or hyperkalemia status. 1
Standard Dose Protocol
The dose remains 0.01 mg/kg IV/IO for all pediatric cardiac arrest patients, including those with renal impairment and hyperkalemia. 1 This translates to 0.1 mL/kg of the 1:10,000 solution (0.1 mg/mL concentration). 1
- Maximum single dose is 1 mg regardless of patient weight 1
- Use IV or IO routes preferentially; these provide more predictable drug levels than endotracheal administration 1
- If endotracheal administration is necessary (no vascular access), use a higher dose of 0.1 mg/kg to compensate for reduced bioavailability 1
Dosing Frequency: Every 3-5 Minutes
Repeat epinephrine every 3-5 minutes throughout the resuscitation until return of spontaneous circulation (ROSC). 2, 1
The evidence on optimal dosing intervals is complex and somewhat contradictory:
- Avoid dosing more frequently than every 3 minutes: Very-low-certainty evidence suggests that intervals less than 3 minutes are associated with lower 12-month survival (adjusted OR 0.50; 95% CI, 0.24-1.06) compared to 3-5 minute intervals 2
- The 2020 International Consensus cannot make a firm recommendation about optimal subsequent dose intervals due to very low confidence in the evidence 2
- The 3-5 minute interval represents the safest approach balancing potential benefit with avoiding harm from excessive dosing 1
Critical Timing Considerations
For nonshockable rhythms (asystole, PEA), administer the initial epinephrine dose as early in the resuscitation as possible. 2 This is a weak recommendation based on very-low-certainty evidence, but early administration is associated with improved outcomes. 2
- For shockable rhythms (VF/pVT), no specific recommendation exists for timing of initial epinephrine 2
- Every minute of delay in the first epinephrine dose decreases survival in nonshockable cardiac arrest 1
High-Dose Epinephrine: Contraindicated
Do not use high-dose epinephrine (0.1 mg/kg or 100 mcg/kg). 1, 3 The highest quality randomized controlled trial demonstrated that high-dose epinephrine as rescue therapy resulted in significantly worse 24-hour survival compared to standard dosing (1/34 vs 7/34 survived; odds ratio for death 8.6; P=0.05). 3
- In asphyxial arrest specifically, high-dose epinephrine was particularly harmful: 0/12 survived at 24 hours with high-dose vs 7/18 with standard dose (P=0.02) 3
- High-dose epinephrine does not improve return of spontaneous circulation rates 3
- The American Academy of Pediatrics explicitly states that high-dose epinephrine is associated with reduced 24-hour survival and does not improve neurologic outcomes 1
Special Considerations for Renal Impairment and Hyperkalemia
The standard epinephrine dose does not require adjustment for acute kidney injury or hyperkalemia during cardiac arrest. The immediate life-threatening nature of cardiac arrest supersedes concerns about epinephrine's potential renal effects or exacerbation of hyperkalemia.
- While epinephrine dosing (both total number and frequency) has been identified as a risk factor for post-arrest acute kidney injury 4, this does not justify withholding or reducing doses during active resuscitation
- Hyperkalemia itself is a potentially reversible cause of cardiac arrest and should be treated concurrently with calcium chloride or calcium gluconate, sodium bicarbonate, and other standard therapies 1
- The priority during cardiac arrest is achieving ROSC; renal protection strategies are secondary
Administration Technique
- Administer during ongoing chest compressions—do not interrupt compressions for drug administration 1
- Prepare doses in advance to minimize delays 1
- Verify concentration before administration: confusion between 1:1,000 and 1:10,000 concentrations can be fatal 1
- Follow each dose with a saline flush to ensure drug delivery 1
Common Pitfalls to Avoid
- Do not dose more frequently than every 3 minutes in an attempt to improve outcomes—this may worsen survival 2, 1
- Do not escalate to high-dose epinephrine if standard doses fail—continue standard dosing 1, 3
- Do not delay the first dose in nonshockable rhythms while establishing "perfect" access—use IO if IV access is delayed 1
- Do not reduce or withhold epinephrine due to concerns about renal function or hyperkalemia during active cardiac arrest—achieving ROSC is the priority